Valiant Labs Q3 FY26: revenue doubles YoY, 9M standalone turns profitable

Revenue growth above 20%Net loss reportedResults View source PDF Explain this filing

VALIANTLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.8%Reaction day

₹65.61

prior close

₹67.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.5%-4.3% vs market

On the reaction day the stock moved 4.3 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-3.1

10m

-3.3

15m

-4.5

30m

-5.1

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

-4.8-0.5-4.3

Next day

-6.7-2.0-4.7

-6.6-2.7-4.0

-10.0-1.7-8.2

-9.9-1.4-8.5

-8.7-2.8-5.9

-9.9-2.8-7.1

15d

-19.8-8.4-11.3

-18.4-9.1-9.3

-10.2-4.0-6.1

+21.9+2.6+19.3

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved audited Q3 and 9M FY26 results. Standalone Q3 revenue grew 55% YoY to Rs 5474.42 lakhs. 9M revenue nearly doubled to Rs 15173.91 lakhs. Standalone 9M net profit was Rs 201.54 lakhs versus a loss of Rs 538.85 lakhs last year, a turnaround. Q3 standalone PAT fell sharply to Rs 3.30 lakhs. Consolidated 9M net loss widened to Rs 503.52 lakhs, hit by subsidiary losses.

Likely market impact

Strong revenue growth and 9M standalone turnaround are positive, but weak Q3 PAT and consolidated losses may cap upside.